Venture Capital

Noaber

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO

Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia, Romania

Industries Focus

  • Technology
  • Healthcare
  • Digital Health
  • Pharmaceuticals
  • Medical Devices
  • Diagnostics
  • Biotechnology
  • Health and Wellness
  • Health Services
  • Medical Research
  • Medical Equipment
  • Health Insurance
  • Health IT
  • Telemedicine
  • Medical Education

Investment Size:
100,000 to 3,000,000 USD

Investor Details Founded: 2000

Noaber is a Dutch venture capital firm dedicated to driving transformative change in the healthcare sector. Their mission is to improve health outcomes by investing in innovative companies that contribute to a healthier society. They focus on initiatives that enhance the quality of care, reduce costs, and increase patient and provider satisfaction, aligning with the quadruple aim in healthcare management.

The firm's investment strategy centers on four key areas: health activation, early screening and diagnostics, smart chronic disease management, and health systems. They typically invest in companies at various stages, from pre-seed to growth, providing capital and strategic support to accelerate development and market adoption. Noaber's portfolio includes direct investments in companies like Alba Health and Momo Medical, as well as indirect investments through funds such as Rockstart and NLC.

Noaber distinguishes itself through its long-term investment horizon and commitment to measuring concrete healthcare improvements. Their evaluation framework examines both financial returns and tangible impact metrics, including clinical outcomes, provider efficiency, cost reduction, and accessibility improvements. This dual-return philosophy has positioned Noaber as a pioneer in impact investing within the healthcare sector, particularly across European markets where they maintain a strong presence.

Beyond direct investments, Noaber actively fosters collaboration among stakeholders throughout the healthcare ecosystem. They facilitate partnerships between portfolio companies, healthcare institutions, payers, and regulatory bodies to address implementation barriers and accelerate adoption of promising innovations. This ecosystem approach reflects Noaber's understanding that meaningful healthcare transformation requires coordinated effort across multiple domains. Their commitment to the quadruple aim demonstrates a sophisticated understanding that sustainable healthcare improvement must simultaneously address patient outcomes, experience, costs, and provider wellbeing to create lasting value.

Requirements
  • Innovative healthcare solutions
  • Scalable business models
  • Positive impact on health outcomes
  • Alignment with Noaber's mission and values
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Alba Health
  • Momo Medical
  • Sweetch
  • Plasmacure
  • Buurtdokters
  • Voeding Leeft
  • Join Us
  • GelijkGezond
Claim this Investor

Are you an official representative of Noaber?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim